Metatron Hunter 4025 Helps in the Treatment of Ovarian Cancer
Metatron Hunter 4025 and NLS imaging of ovarian cancer
Recent decades have seen achievements in the treatment of certain forms of malignancies, but ovarian cancer (OC) remains a disease with a rather unfavorable prognosis. Ovarian cancer is usually diagnosed at stages III-IV; the 5-year survival rates at this time are approximately 27% and 16%, respectively. This is why it is urgent to discover new methods for early detection of OC. We first evaluated OC screening by NLS examination combined with the role of ultrasound studies in 2001-2003. We found that this screening program improved survival. Since then, however, transvaginal ultrasound research has been widely disseminated and methods of ultrasound data interpretation have been updated; a new system for NLS research with digitally triggered sensors was created - which allows us to apply continuous helical scanning in the screening process. New methods; 3D visualization of research results is introduced. All these changes resulted in a significant increase in study accuracy.
This can be done by using a metatron Hunter 4025 with generator frequency 4.9 GHz, digital trigger sensor and NLS-graphy equipped with a continuous helical scan unit. To cooperate with the system, we used the professional computer software metatron 4024 Hunter, which has the function of 3D visualization of research results.
Data from metatron Hunter 4025 is playing an increasingly important role in medicineļ¼the role he can play is obviously changing modern medicine, and will be involved in more treatments in the future, bringing more help to the medical community, It is also a place that brings more health and happiness to people!